“…In addition, epidemiological studies conducted over the last 2 decades have demonstrated that CF occurs more commonly than previously thought in populations of non-European descent, and the disease is now recognized in many parts of the world ( Bell et al, 2020a ). It is estimated that CF affects approximately 72,000 patients worldwide ( Hammoudeh et al, 2021 ), with a rate of 1/2000 in European ancestry populations ( Gajbhiye and Gaikwad, 2017 ), an incidence of 1 in 12,000 in South Africa’s mixed ancestry population ( Carles et al, 1996 ; Feuillet-Fieux et al, 2004 ) and an incidence of 1 in 14,000 in African American black people. However, the occurrence of CF in black African populations with no European ancestry contribution is unknown ( Carles et al, 1996 ).…”